|
Volumn 52, Issue 5, 2002, Pages 971-978
|
A Trial of the Effectiveness of Artificial Dermis in the Treatment of Patients with Burns Greater Than 45% Total Body Surface Area
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOBRANE;
CEFTAZIDIME;
CILASTATIN PLUS IMIPENEM;
CIPROFLOXACIN;
ERYTHROMYCIN;
FLUCONAZOLE;
GENTAMICIN;
MAFENIDE;
MAFENIDE ACETATE;
OXACILLIN;
PENICILLIN G;
PIPERACILLIN;
SILVER NITRATE;
VANCOMYCIN;
ADOLESCENT;
ADULT;
ANTIBIOTIC PROPHYLAXIS;
ARTICLE;
ARTIFICIAL SKIN;
ASPERGILLUS FUMIGATUS;
BURN;
BURN INFECTION;
CANDIDA ALBICANS;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEVICE;
DISEASE COURSE;
ENTEROBACTER CLOACAE;
FEMALE;
GAUZE;
HUMAN;
INFECTION RATE;
LUNG BURN;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCHOOL CHILD;
SKIN SURGERY;
STAPHYLOCOCCUS AUREUS;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
BODY SURFACE AREA;
BURNS;
CHILD;
DERMIS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
SKIN, ARTIFICIAL;
SURGICAL WOUND INFECTION;
WOUND HEALING;
|
EID: 0036095058
PISSN: 00225282
EISSN: None
Source Type: Journal
DOI: 10.1097/00005373-200205000-00024 Document Type: Article |
Times cited : (34)
|
References (8)
|